- IRMS - Nicolae Testemitanu SUMPh
- REVISTE MEDICALE NEINSTITUȚIONALE
- Arta Medica
- Arta Medica 2018
- Arta Medica Vol. 67, No 2, 2018 ediție specială
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/9421
Title: | Evaluarea proteinei C reactive la pacienţii cu bronhopneumopatie obstructivă cronică în exacerbare |
Other Titles: | Evaluation of C-reactive protein in patients with chronic obstructive pulmonary disease in exacerbation |
Authors: | Popa, Ana Matcovschi, Sergiu Caproş, Natalia Şveţ, Svetlana Lupan, Mihail |
Keywords: | Chronic obstructive obstructive bronchopneumopathy;reactive C protein;inflammatory marker |
Issue Date: | 2018 |
Publisher: | Asociaţia chirurgilor “Nicolae Anestiadi” din Republica Moldova |
Citation: | POPA, Ana, MATCOVSCHI, Sergiu, CAPROŞ, Natalia, et al. Evaluarea proteinei C reactive la pacienţii cu bronhopneumopatie obstructivă cronică în exacerbare. In: Arta Medica. 2018, nr. 2(67), pp. 60-62. ISSN 1810-1852. |
Abstract: | Scopul studiului a fost de a evalua nivelul proteinei C reactive la pacienţii cu bronhopneumopatie obstructivă cronică în exacerbare. Studiul a fost efectuat
pe un lot de 100 de pacienţi cu bronhopneumopatie obstructivă cronică GOLD II-IV în exacerbare, care au fost investigaţi clinic şi paraclinic conform ghidului
GOLD 2017. Rezultatele investigației au arătat valori crescute ale CRP la toți pacienții cu bronhopneumopatie obstructivă cronică, predominant la cei cu tipul
D și B cu grad sever de boală comparativ cu tipul C. Valoarea crescută a proteinei C reactive la pacienții cu bronhopneumopatie obstructivă cronică poate
constitui un factor predictiv pentru o exacerbare severă actuală și fundamenta tratamentul oportun. The aim of the study was to evaluate the level of C reactive protein in patients with chronic obstructive pulmonary disease in exacerbation. The study was performed on a group of 100 patients with chronic obstructive pulmonary disease GOLD II-IV in exacerbation, that were clinically and paraclinically
investigated according to the GOLD 2017 guideline. The results of the study showed elevated C reactive protein values in all patients with chronic obstructive
pulmonary disease, predominantly in those with D and B types compared to type C. Increased C reactive protein value in patients with chronic obstructive
pulmonary disease may be a predictive factor for a current severe exacerbation and argue the oportun treatment. |
URI: | https://artamedica.md/old_issues/ArtaMedica_67.pdf http://repository.usmf.md/handle/20.500.12710/9421 |
ISSN: | 1810-1852 |
Appears in Collections: | Arta Medica Vol. 67, No 2, 2018 ediție specială
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|